Carl Osborne, DVM

Carl is the Founder and Managing Director of SciLucent. Carl has assisted in the development or reorganization of dozens of companies in the U.S., Europe, and Asia. In addition, he has overseen the due diligence of hundreds of healthcare products for companies operating worldwide. Carl has designed and managed the implementation of global development and commercialization programs for human and veterinary drugs, medical devices, biological products, combination products and novel drug delivery systems. He has been responsible for integrating development activities (nonclinical, clinical, CMC, and marketing) with regulatory and business strategies for clients worldwide. He developed and implemented strategies and programs to support the evaluation, registration, and manufacturing of traditional, natural, and biotech healthcare products. He is a former reviewer, toxicologist, and compliance officer for the FDA with extensive experience in manufacturing and cGMPs implementation and management. Carl has a D.V.M. from the Virginia–Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University. He is the lead editor of the book “The Expert’s Guide to Healthcare Product Due Diligence” published by the Food and Drug Law Institute.